Poxel SA (EURONEXT:POXEL)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - POXEL

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - POXEL

  • Market Cap€198.840m
  • SymbolEURONEXT:POXEL
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINFR0012432516

Company Profile

Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH). It has developed a portfolio of drug candidates, including its three most advanced candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.Poxel SA is a biopharmaceutical company. It is developing drugs for metabolic diseases, in particular Type 2 diabetes.

Latest POXEL news

Currently there for this company. Visit our news hub for other news .